United States · FDA National Drug Code directory
Methocarbamol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-534_bf48c1c6-3723-1fde-e053-2995a90af824
- Product NDC
- 31722-534
- Form
- TABLET
- Composition / generic term
- Methocarbamol
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130320
- Source listing expiry
- 20261231
Source-listed ingredients
- METHOCARBAMOL — 750 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 12 BOTTLE in 1 CASE (31722-534-01) / 100 TABLET in 1 BOTTLE · 31722-534-01
- 12 BOTTLE in 1 CASE (31722-534-05) / 500 TABLET in 1 BOTTLE · 31722-534-05
- 12 BOTTLE in 1 CASE (31722-534-30) / 30 TABLET in 1 BOTTLE · 31722-534-30
- 12 BOTTLE in 1 CASE (31722-534-60) / 60 TABLET in 1 BOTTLE · 31722-534-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →